Skip to content
Recall Observatory FDA recall evidence

Device product

ELUVIA Drug-Eluting Vascular Stent System - Product Usage: indicated for improving luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the native superficial femoral artery (SFA) and/or proximal popliteal artery with reference vessel diameters (RVD) ranging from 4.0-6.0 mm and total lesion lengths up to 190 mm.

Z-1621-2021

April 21, 2021

Class II

Product summary

Firm
Boston Scientific Corporation
Event
Event 87839
Status
Terminated
Classification
Class II
Quantity
27 UNITS
Official record key
device-enforcement:Z-1621-2021

Official wording

Reason: One batch of the ELUVIATM Drug Eluting Vascular Stent System incorrect placement of some 6x40mm ELUVIA stents into 6x100mm packaging.

Code information: LOT: 25838357

Distribution pattern: US Nationwide distribution in the states of AL, AR, AZ, CA, DE, HI, IL, KS, KY, MA, MD, NC, NJ, NV, NY, OH, OK, PA,PR, TX, VA,WA,WV.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    One batch of the ELUVIATM Drug Eluting Vascular Stent System incorrect placement of some 6x40mm ELUVIA stents into 6x100mm packaging.

Field note

Send feedback

We'll only use this to respond to your feedback.